IL15 and hepatocellular carcinoma: To investigate the antiviral response of both IL2/IL15-NKs and IFNα-NKs, cells were challenged with human hepatoma HuH-7 cell line derivative Huh7.5 infected with the HCV-JFH1 replicon (from now on indicated as HCV-Huh7.5) [17].